Published in Physician Law Weekly, February 8th, 2006
Acacia expects to complete the transaction in the second quarter of 2006 subject to receiving a satisfactory tax opinion from legal counsel and completing the required filings with the U.S. Securities and Exchange Commission. If the conditions are met, Acacia will redeem all of the issued and outstanding shares of Acacia Research-CombiMatrix common stock (CBMX) for all of the common stock of CombiMatrix Corporation, which will register its stock under the Securities Act of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.